Skip to main content
. 2024 Nov 4;65(13):2. doi: 10.1167/iovs.65.13.2

Table 4.

Results of GEE Models Adjusted for Age and Sex Comparing Electroretinography (ERG) Results in Eyes of People With Multiple Sclerosis Both With (MS +ON) and Without (MS −ON) Previous Optic Neuritis With Those of HC Participants

Variable Coefficient Estimate SE 95% CI P Value
DA0.01b.AMP HC (intercept) 440.04 35.24 370.96 to 509.12
MS −ON 11.54 15.22 −18.3 to 41.37 0.77
MS +ON 18.97 16.49 −13.34 to 51.28 0.55
DA0.01b.PEAK HC (intercept) 74.87 2.76 69.47 to 80.27
MS −ON −0.55 1.17 −2.84 to 1.75 0.81
MS +ON 0.23 1.44 −2.59 to 3.06 0.95
DA3.0a.AMP HC (intercept) −387.52 23.62 −433.81 to −341.22
MS −ON −0.43 10.31 −20.63 to 19.78 0.97
MS +ON −3.63 12.12 −27.39 to 20.13 0.88
DA3.0a.PEAK HC (intercept) 14.04 0.27 13.51 to 14.57
MS −ON 0.19 0.12 −0.03 to 0.42 0.28
MS +ON 0.30 0.13 0.05 to 0.54 0.089
DA3.0b.AMP HC (intercept) 589.10 43.26 504.32 to 673.89
MS −ON 14.33 19.29 −23.47 to 52.13 0.77
MS +ON 29.22 20.48 −10.91 to 69.36 0.37
DA3.0b.PEAK HC (intercept) 48.48 1.36 45.8 to 51.15
MS −ON 2.10 0.67 0.78 to 3.42 0.014
MS +ON 3.42 0.85 1.75 to 5.08 0.001
LA3.0a.AMP HC (intercept) −56.69 4.28 −65.08 to −48.29
MS −ON −1.32 1.94 −5.13 to 2.48 0.77
MS +ON −1.18 2.31 −5.7 to 3.34 0.81
LA3.0a.PEAK HC (intercept) 13.60 0.26 13.08 to 14.12
MS −ON 0.18 0.11 −0.03 to 0.38 0.28
MS +ON 0.08 0.16 −0.23 to 0.39 0.81
LA3.0b.AMP HC (intercept) 259.44 19.42 221.39 to 297.5
MS −ON 5.67 8.69 −11.36 to 22.7 0.77
MS +ON 2.67 9.24 −15.44 to 20.78 0.88
LA3.0b.PEAK HC (intercept) 27.72 0.55 26.64 to 28.8
MS −ON 0.36 0.24 −0.11 to 0.82 0.35
MS +ON 0.49 0.25 −0.01 to 0.98 0.22
Flicker.AMP HC (intercept) 167.16 12.20 143.24 to 191.08
MS −ON 4.25 5.17 −5.88 to 14.37 0.77
MS +ON 0.21 5.78 −11.12 to 11.53 0.97
Flicker.PEAK HC (intercept) 23.78 0.71 22.39 to 25.16
MS −ON 1.01 0.30 0.43 to 1.6 0.009
MS +ON 1.09 0.36 0.39 to 1.79 0.014

AMP, response amplitude (in microvolts); CI, confidence interval; PEAK, response peak time (in milliseconds).

Corrected P values representing moderate, strong, or very strong evidence of a difference between the relevant MS subgroup and HC cohort are highlighted in bold (more details available in the Methods section and the Statistical Analysis subsection).